Time for a Change? Looking Ahead at New Treatment Strategies for the Management of Dyslipidemia
This Continuing Education activity is supported by an educational grant from Merck Sharp & Dohme Corp.
This activity is supported by an educational grant from Merck Sharp & Dohme Corp.
Faculty
Patrick Curtin PharmD, BCPS
Clinical Coordinator
Overlook Medical Center
Summit, New Jersey
Educational Objectives
After completing this continuing education program, the participant will be able to:
- Examine the changes to previous guidelines as presented in the 2013 American Heart Association/ American College of Cardiology lipid guidelines.
- Determine the use of the pooled cohort equations for the assessment of patients’ 10-year atherosclerotic cardiovascular risk.
- Identify available and investigational medications and treatment strategies to develop patient-specific management of dyslipidemia.
Target audience:
Pharmacists
Type of activity:
Application
Release date:
July 6, 2015
Expiration date:
July 6, 2017
Estimated time to complete activity
: 2.0 hours
Fee:
Free
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-15-068-H01-P. The activity is available for CE credit through July 6, 2017.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025